SHANGHAI, Aug 27 (Reuters) – China’s drug regulator has accepted Novo Nordisk’s marketing application for the oral version of its weight-loss drug Wegovy, the Danish drugmaker said in a statement on Thursday.
(Reporting by Andrew Silver in Shanghai; Editing by Clarence Fernandez)
